A baya-bayan nan, Shanghai Epiprobe Biotechnology Co., Ltd. (ana nufin "Epiprobe") ya sanar da cewa ya kammala kusan RMB miliyan 100 a cikin tallafin Series B, wanda babban birnin masana'antu, dandamalin saka hannun jari na gwamnati ...
Kara karantawa